Skip to content

Clinical trials

Phase 1/2 Immunoblastic Lymphadenopathy trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immunoblastic Lymphadenopathy Phase: Phase 1/2 Country / region: United States Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20031
20051
20061
20072
20083
20091
20112
20131
20141
20151
20171
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
City of Hope Medical Center2
Fred Hutchinson Cancer Center2
M.D. Anderson Cancer Center2
Mayo Clinic2
National Cancer Institute (NCI)2
Northwestern University2
Acrotech Biopharma Inc.1
Cancer Treatment Centers of America1
Celgene1
Massachusetts General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immunoblastic Lymphadenopathy20
Lymphoma, Large-Cell, Anaplastic19
Lymphoma, Follicular13
Lymphoma, Large B-Cell, Diffuse13
Mycosis Fungoides13
Hodgkin Disease12
Lymphoma, B-Cell, Marginal Zone12
Lymphoma, Mantle-Cell12
Waldenstrom Macroglobulinemia12
Burkitt Lymphoma11

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.